Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 13/865,649, filed Apr 18, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,403,867 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 9,872,883 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 9,956,261 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 9,981,002 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 10,300,105 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 10,576,122 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| US 10,905,737 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content In force · High confidence | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | In force | High confidence | ||
| Application 13/865,649 | Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content Abandoned Abandoned Sep 21, 2017 | Helsinn Healthcare S.A. and Ono Pharmaceutical Co., Ltd. | Abandoned | Abandoned Sep 21, 2017 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Ono Pharmaceutical Co., Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.